InterventionsHumans12 adultsCohort study

Efficacy and safety of semaglutide for obesity and hyperphagia in adults with Prader-Willi syndrome

Figure 1. Adverse event outcomes in participants with PWS treated with semaglutide.
Open the figure at full size
Figure 1. Adverse event outcomes in participants with PWS treated with semaglutide.Adverse event outcomes in participants with PWS treated with semaglutide.Ahmed et al.

Frontiers in Endocrinology

The paper

Ahmed S, Bridges N, Goldstone AP

Frontiers in Endocrinology · 3 Sep 2026

doi.org/10.3389/fendo.2026.1881392PubMed 42755517

More on GLP1R